RYR mutation G1021A (Gly341Arg) is not frequent in Danish and Swedish families with malignant hyperthermia susceptibility

Clinical Genetics

Volumn 49, Issue 4, 1996, Pages 186-188

  Fagerlund, T ^a,b   Ording H ^c   Bendixen, D ^c   Islander, G ^d   Ranklev Twetman, E ^d   Berg, K ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

DNA; Genetics; Human mutation; Malignant hyperthermia; Mutation Gly341Arg; RYR1; Scandinavian population

Indexed keywords

INHALATION ANESTHETIC AGENT; NEUROMUSCULAR DEPOLARIZING AGENT; SUXAMETHONIUM;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; DENMARK; FAMILY STUDY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT HYPERTHERMIA; PHENOTYPE; PRIORITY JOURNAL; SWEDEN;

EID: 0029884111     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1996.tb03284.x     Document Type: Article

References (9)

1. Alestrøm A, Fagerlund TH, Berg K. A simple method to detect the RYR1 mutation G1021A, a cause of malignant hyperthermia susceptibility. Clin Genet 1995: 47: 274-275.
2. European Malignant Hyperpyrexia Group. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth 1984: 56: 126-269.
3. European Malignant Hyperpyrexia Group. Laboratory diagnosis of malignant hyperpyrexia susceptibility (MHS). Br J Anaesth 1985: 57: 1038.
4. Fagerlund T, Ørding H, Bendixen D, Berg K. Search for three known mutations in the RYR1 gene in 48 Danish families with malignant hyperthermia. Clin Genet 1994: 46: 401-404.
5. Fagerlund TH, Islander G, Twetman ER, Berg K. A search for three known RYR1 gene mutations in 41 Swedish families with predisposition to malignant hyperthermia. Clin Genet 1995: 48: 12-16.
6. Haliassos A, Chomel JC, Tesson L, Baucis M, Kruh J, Caplan JC, Kitzis A. Modification of enzymatically amplified DNA for the detection of point mutation. Nucleic Acids Res 1989: 17: 3606.
7. MacLennan DH, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk RG, Frodis W, Britt BA, Worton RG. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 1990: 343: 559-561.
8. McCarthy TV, Healy JMS, Heffron JJA, Lehane M, Deufel T, Lehmann-Horn F, Farral M, Johnson K. Localisation of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature 1990: 343: 562-564.
9. Quane KA, Keating KE, Manning BM, Healy JMS, Monsieurs K, Heffron JJA, Lehane M, Heytens L, Krivosic, Horbert R, Adnet P, Ellis FR, Monnier N, Lunard J, McCarthy TV. Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies. Hum Mol Genet 1994: 3: 471-476.